Molecular detection was based on the RT-PCR amplification of at least two viral genome regions. The assays used by our laboratory during the study period were the Cobas SARS-CoV-2 assay (“ROC”, Roche Molecular Diagnostics, Mannheim, Germany), Alinity m SARS-CoV-2 assay (“ALI”, Abbott Molecular, Rungis, France), NeuMoDx SARS-CoV-2 assay (“NMDx”, Qiagen, Courtaboeuf, France), Xpert Xpress SARS-CoV-2 assay (“CPH”, Cepheid, Maurens-Scopont, France), and Simplexa COVID-19 Direct assay (“SPX”, DiaSorin, Antony, France).
Our laboratory information system collected results expressed as cycle threshold (Ct) values. For assays with multiple targets, the mean Ct value was calculated.